Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001013762-25-004366
Filing Date
2025-03-28
Accepted
2025-03-28 20:55:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 13668
  Complete submission text file 0001013762-25-004366.txt   15461
Mailing Address 888 BOYLSTON, SUITE 500 BOSTON MA 02199
Business Address 888 BOYLSTON, SUITE 500 BOSTON MA 02199 (617) 449-7700
M33 Growth I L.P. (Filed by) CIK: 0001718621 (see all company filings)

EIN.: 822962623 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Subject) CIK: 0001799191 (see all company filings)

EIN.: 843562323 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91458 | Film No.: 25788424
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine
(CF Office: 08 Industrial Applications and Services)